- Home
- CYCN vs VCIG Comparison
CYCN vs VCIG Comparison
Compare CYCN & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCN
- VCIG
- Stock Information
- Founded
- CYCN 2018
- VCIG 2013
- Country
- CYCN United States
- VCIG Malaysia
- Employees
- CYCN N/A
- VCIG N/A
- Industry
- CYCN Biotechnology: Pharmaceutical Preparations
- VCIG Diversified Commercial Services
- Sector
- CYCN Health Care
- VCIG Consumer Discretionary
- Exchange
- CYCN Nasdaq
- VCIG Nasdaq
- Market Cap
- CYCN 7.6M
- VCIG 7.5M
- IPO Year
- CYCN N/A
- VCIG 2023
- Fundamental
- Price
- CYCN $1.41
- VCIG $1.65
- Analyst Decision
- CYCN
- VCIG
- Analyst Count
- CYCN 0
- VCIG 0
- Target Price
- CYCN N/A
- VCIG N/A
- AVG Volume (30 Days)
- CYCN 1.0M
- VCIG 8.5M
- Earning Date
- CYCN 11-07-2025
- VCIG 10-06-2025
- Dividend Yield
- CYCN N/A
- VCIG N/A
- EPS Growth
- CYCN N/A
- VCIG N/A
- EPS
- CYCN N/A
- VCIG 0.98
- Revenue
- CYCN $2,174,000.00
- VCIG $32,903,041.00
- Revenue This Year
- CYCN N/A
- VCIG N/A
- Revenue Next Year
- CYCN N/A
- VCIG N/A
- P/E Ratio
- CYCN N/A
- VCIG $1.73
- Revenue Growth
- CYCN N/A
- VCIG 24.77
- 52 Week Low
- CYCN $1.27
- VCIG $0.91
- 52 Week High
- CYCN $9.47
- VCIG $4,644.00
- Technical
- Relative Strength Index (RSI)
- CYCN 34.60
- VCIG 40.29
- Support Level
- CYCN $1.60
- VCIG $0.93
- Resistance Level
- CYCN $2.23
- VCIG $2.18
- Average True Range (ATR)
- CYCN 0.16
- VCIG 0.43
- MACD
- CYCN -0.03
- VCIG 0.07
- Stochastic Oscillator
- CYCN 2.41
- VCIG 28.78
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.